IL7
Basic information
Region (hg38): 8:78675743-78805523
Links
Phenotypes
GenCC
Source:
- epidermodysplasia verruciformis (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Epidermodysplasia verruciformis, susceptibility to, 5 | AR | Allergy/Immunology/Infectious; Oncologic | Individuals have been described with susceptibility to certain infections as well as potential increased risk of skin cancer, and awareness may allow prompt diagnosis and management of sequeleae | Allergy/Immunology/Infectious; Dermatologic; Oncologic | 25981006 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 6 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 1 | |||||
Total | 0 | 0 | 5 | 0 | 3 |
Variants in IL7
This is a list of pathogenic ClinVar variants found in the IL7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-78678605-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
8-78678675-C-T | not specified | Uncertain significance (Sep 26, 2022) | ||
8-78686500-A-G | not specified | Uncertain significance (Aug 02, 2023) | ||
8-78686519-T-C | not specified | Uncertain significance (May 04, 2023) | ||
8-78686584-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
8-78689251-A-T | Uncertain significance (Aug 05, 2023) | |||
8-78689309-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
8-78689315-G-C | not specified | Uncertain significance (Dec 09, 2023) | ||
8-78689342-C-T | not specified | Uncertain significance (May 09, 2022) | ||
8-78689363-G-A | not specified | Uncertain significance (Oct 05, 2021) | ||
8-78689371-G-C | not specified | Uncertain significance (Jun 22, 2023) | ||
8-78697419-G-A | not specified | Uncertain significance (May 24, 2023) | ||
8-78697419-G-T | not specified | Uncertain significance (May 06, 2024) | ||
8-78697468-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
8-78697483-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
8-78697488-G-A | not specified | Likely benign (Feb 16, 2023) | ||
8-78697489-C-A | not specified | Uncertain significance (Jul 14, 2023) | ||
8-78698409-A-G | Likely benign (Mar 01, 2023) | |||
8-78733733-T-C | not specified | Uncertain significance (May 18, 2023) | ||
8-78736505-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
8-78736524-T-C | not specified | Uncertain significance (Jan 25, 2023) | ||
8-78738498-G-A | IL7-related disorder | Benign (Oct 28, 2019) | ||
8-78738508-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
8-78738523-A-T | not specified | Uncertain significance (Mar 19, 2024) | ||
8-78740025-T-A | Epidermodysplasia verruciformis, susceptibility to, 5 | risk factor (Feb 01, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL7 | protein_coding | protein_coding | ENST00000263851 | 6 | 129781 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.926 | 0.0739 | 125294 | 0 | 1 | 125295 | 0.00000399 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.705 | 67 | 85.3 | 0.785 | 0.00000400 | 1178 |
Missense in Polyphen | 9 | 20.084 | 0.44812 | 310 | ||
Synonymous | 0.372 | 27 | 29.6 | 0.913 | 0.00000134 | 299 |
Loss of Function | 2.67 | 0 | 8.31 | 0.00 | 3.48e-7 | 120 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000883 | 0.00000883 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hematopoietic growth factor capable of stimulating the proliferation of lymphoid progenitors. It is important for proliferation during certain stages of B-cell maturation.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Jak-STAT signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);JAK-STAT-Core;IL-7 Signaling Pathway;Development and heterogeneity of the ILC family;PI3K-Akt Signaling Pathway;Cytokines and Inflammatory Response;Interleukin-7 signaling;Signaling by Interleukins;Cytokine Signaling in Immune system;JAK STAT MolecularVariation 1;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Immune System;GPCR signaling-G alpha s Epac and ERK;IL-7 signaling;GPCR signaling-G alpha s PKA and ERK;JAK STAT pathway and regulation;GPCR signaling-G alpha i;IL-7
(Consensus)
Recessive Scores
- pRec
- 0.496
Intolerance Scores
- loftool
- 0.140
- rvis_EVS
- 0.21
- rvis_percentile_EVS
- 67.72
Haploinsufficiency Scores
- pHI
- 0.107
- hipred
- N
- hipred_score
- 0.419
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.903
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il7
- Phenotype
- immune system phenotype; hematopoietic system phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- positive regulation of cytokine-mediated signaling pathway;T cell lineage commitment;humoral immune response;cell-cell signaling;positive regulation of cell population proliferation;animal organ morphogenesis;regulation of gene expression;regulation of signaling receptor activity;cytokine-mediated signaling pathway;positive regulation of B cell proliferation;positive regulation of chemokine production;interleukin-7-mediated signaling pathway;negative regulation of apoptotic process;negative regulation of catalytic activity;bone resorption;positive regulation of T cell differentiation;positive regulation of organ growth;homeostasis of number of cells within a tissue;regulation of peptidyl-tyrosine phosphorylation;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
- Cellular component
- extracellular region;extracellular space;collagen-containing extracellular matrix
- Molecular function
- cytokine activity;interleukin-7 receptor binding;protein binding;growth factor activity